Antithrombotic therapy in stable cardiovascular disease - Represented in NEJM by the COMPASS trial and the PEGASUS-TIMI 54 trial

26 August 2018 (08:30 - 08:52)
Organised by:
Congress Presentation Part of: Highlights from the New England Journal of Medicine: Editors’ Choice Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS) ESC Premium Access ESC Congress 2018